spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Lorus Therapeutics 

 HSMN NewsFeed - 2 Dec 2013
Lorus Therapeutics Completes New Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2013
Lorus Therapeutics Appoints New Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Jun 2010
Lorus Therapeutics Files Investigational New Drug Application With FDA for Anticancer Drug LOR-253
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Dec 2009
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jun 2008
Lorus Therapeutics announces that the European Medicines Agency (EMEA) has granted the orphan drug designation to LOR-2040 for the treatment of Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 May 2008
Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Apr 2008
Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 22 Jan 2008
Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jun 2007
Lorus Therapeutics announces the initiation of a clinical trial of GTI-2040 in acute leukemia and myelodysplastic syndrome
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Sep 2006
Lorus Therapeutics announces that Dr. Jim A. Wright will step down as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2006
Lorus Therapeutics announces the appointment of a new President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2006
Chemokine Therapeutics names Guy Ely, MD as Chief Medical Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 24

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 24 additional stories matching:
Lorus Therapeutics
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.